Abstract:Objective To investigate the clinical efficacy of rivaroxaban on preventing deep vein thrombosis(DVT)in postoperative hip arthroplasty.Methods 81 patients with hip arthroplasty by operation in our hospital from March 2011 to Spe.2012 were selected and randomly divided into two groups,rivaroxaban and low molecular weight heparin(LMWH)groups,40 cases in rivaroxaban group and 40 cases in LMWH group.The rivaroxaban group was given oral rivaroxaban 10 mg at postoperative 6 h,once a day for continuous 2 weeks.The LMWH group was given LMWH 4100IU/d with in postoperative 12 h,by subcutaneous injection for continuous 2 weeks.The DVT formation was detected by color Doppler ultra sound and compared between two groups after 2 week treatment.Results 5 case had DVT in the LMWH group with the occurrence rate of 12.5% and 2 cases had DVT in the rivaroxaban group with the occurrence rate of 4.9% ,showing statistical difference between the two groups(P < 0.05).The rivaroxaban group had no obvious adverse reactions.Conclusion Rivaroxaban can effectively prevent postoperative DVT in hip arthroplasty and has good security with less adverse reactions,which can be used in clinical practice.

Efficacy comparison of rivaroxaban and Low Molecular Weight heparin in preventing deep venous thrombosis after hip replacement